Programme Thesis
The NSF Engineering Biological and Biomedical Systems (EBBS) program funds fundamental engineering research that advances understanding and control of biological functions across scales—from molecular to organismal—by combining experimental and computational approaches. It exists to enable U.S. leadership in biotechnology by supporting the creation of novel platforms, devices, tissues, and processes that yield mechanistic insights and practical biomedical technologies, excluding drug design, delivery, or clinical trials.
Selection Criteria
Intellectual Merit: potential to advance knowledge in engineering biological/biomedical systems; novelty of the platform, device, or process; rigor of computational and experimental validation. Broader Impacts: benefits to society (e.g., addiction treatment, LMIC health), training of early-career researchers, dissemination to underrepresented groups. Feasibility: clear work plan, appropriate expertise, access to facilities. Alignment with EBBS scope: must focus on engineering principles and biological function control, not drug design or clinical therapy testing. Budget justification: reasonable for proposed work. Data Management Plan: compliant with NSF requirements. Postdoctoral Mentoring Plan (if applicable).
Past Winners / Cohort Profiles
The page does not list specific past winners. Typical EBBS awardees are U.S.-based academic researchers (PI at a university or nonprofit) proposing engineering-driven projects such as novel biosensors, bioreactor control systems, tissue engineering scaffolds, or computational models of neural circuits. Archetypes include early-career faculty with strong computational/experimental integration, often with preliminary data and a clear path to a prototype or platform. No independent researchers or non-U.S. institutions are evident in typical award profiles.
Ideal Candidate Fingerprint
A U.S.-based tenure-track or research faculty member at an accredited university or nonprofit, with a track record in engineering biological systems (e.g., synthetic biology, neural engineering, biomanufacturing). The ideal applicant has preliminary computational and experimental data, a clear engineering platform or device concept, and a plan for broader impacts that includes training and societal benefit. They must be eligible to receive NSF funding directly.
Recommended Framing
Eniola should frame the CCT model and IMPRINT/TOPOLOGIX/GATE platforms as an engineering system for controlling reward-memory encoding in addiction—a novel computational platform that combines systems pharmacology, topological data analysis, and Bayesian modeling to predict and prevent maladaptive learning. The proposal must be submitted through a U.S. academic host (e.g., a collaborator at Michigan, Harvard, Princeton, or NYU) who will serve as PI, with Eniola as a key personnel or co-PI. Emphasize the platform's potential to transform addiction intervention by engineering a closed-loop feedback system (GATE BCI safety + IMPRINT screening) that is fundamentally different from drug design, aligning with EBBS's focus on biological function control.
Watch Out
Eniola is an independent researcher based in Nigeria without a U.S. academic affiliation; NSF grants require the submitting organization to be a U.S. institution (university or nonprofit). He is not yet enrolled in a PhD program, which may weaken the broader impacts case for training. The project's strong pharmacology/addiction focus could be misread as drug design if not carefully framed as engineering of a computational platform. No experimental biology component is mentioned, which EBBS typically expects alongside computation. Budget must be justified for a non-U.S.-based researcher's salary and travel.